A glutamatergic biomarker panel enables differentiating Grade 4 gliomas/astrocytomas from brain metastases.
Lange F, Gade R, Einsle A, Porath K, Reichart G, Maletzki C, Schneider B, Henker C, Dubinski D, Linnebacher M, Köhling R, Freiman TM, Kirschstein T.
Lange F, et al. Among authors: kohling r.
Front Oncol. 2024 May 21;14:1335401. doi: 10.3389/fonc.2024.1335401. eCollection 2024.
Front Oncol. 2024.
PMID: 38835368
Free PMC article.